The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Recruiting
Observational Study
Oncology
Breast Cancer
Prostate Cancer
Gynecologic Cancer
Brain Tumor
Brain Cancer
Gynecologic Tumor
Prostate Tumor
Prostate Neoplasm
Breast Tumor
Radiation Toxicity
Quality of Life
Rectal Cancer
Rectal Tumor
Rectal Neoplasms
Lung Cancer
Lung Tumor
Lung Neoplasm
Esophageal Cancer
Esophagus Cancer
Esophageal Tumor
Esophageal Neoplasm
Esophagus Tumor
Esophagus Neoplasm
Pancreatic Cancer
Pancreatic Tumor
Pancreatic Neoplasms
Head and Neck Cancer
Head and Neck Neoplasms
Head and Neck Tumor
Tumor
Neoplasms
Bladder Cancer
Bladder Neoplasm
Liver Cancer
Liver Neoplasms
Liver Metastases
Oligometastases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 8,000 (estimated)
- Sponsor
- UMC Utrecht · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based implementation of the Unity MR-Linac technology and further technical development of the MR-Linac system with the ultimate purpose to improve patients' survival, local, and regional tumor control and quality of life.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patient is to undergo or has completed imaging or treatment procedures on an MR-Linac;
* Patient provides written, informed consent;
* Patient is 18 years old or older.
Exclusion Criteria:
* MRI exclusion criteria, including
* MRI contraindications as per usual clinical care…
Contacts